HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension.

Abstract
Confirmation of medication adherence is a challenge in clinical practice and essential for the accurate diagnosis of resistant hypertension. Although it is well established that drug adherence is critical for controlling blood pressure, there are still difficulties applying a simple, inexpensive, and reliable assessment of adherence in the clinical setting. We aimed to test a simple method to assess adherence in resistant hypertensive (RH) patients. A pilot study with normotensives or mild/moderate hypertensive subjects was performed to provide a fluorescence cutoff point for adherence. After that, 21 patients referred to the Resistant Hypertension Clinic had triamterene prescribed and were monitored for a 30-day period. We conducted two unannounced randomly selected home visits for urine collection to test drug intake that day. Office, home and 24-hour ambulatory blood pressure, biochemical data, and the 8-item Morisky Medication Adherence Scale (MMAS-8) were systematically acquired. According to adherence indicated by urine fluorescence, subjects were divided into adherent and nonadherent groups. We found 57% of nonadherence. No differences were found between groups regarding baseline characteristics or prescribed medications; Kappa's test showed concordance between adherence through MMAS-8 items and fluorescence (kappa = 0.61; 95% confidence interval: 0.28-0.94; P = .005). Nonadherent patients had higher office (81 ± 11 vs. 73 ± 6 mm Hg, P = .03), 24-hour ambulatory blood pressure monitoring (75 ± 9 vs. 66 ± 7 mm Hg, P = .01), and home blood pressure measurement (77 ± 9 vs. 67 ± 8 mm Hg, P = .01) diastolic blood pressure than their counterparts. Nonadherence to antihypertensive therapy is high in patients with RH, even when assessed in clinics specialized in this condition. Fluorometry to detect a drug in the urine of RH patients is safe, easy, and reliable method to assess adherence.
AuthorsNathália Batista Corrêa, Ana Paula de Faria, Alessandra M V Ritter, Andrea Rodrigues Sabbatini, Aurélio Almeida, Veridiana Brunelli, David A Calhoun, Heitor Moreno, Rodrigo Modolo
JournalJournal of the American Society of Hypertension : JASH (J Am Soc Hypertens) Vol. 10 Issue 6 Pg. 510-516.e1 (06 2016) ISSN: 1878-7436 [Electronic] United States
PMID27161936 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Antihypertensive Agents
  • Diuretics
  • Triamterene
Topics
  • Aged
  • Antihypertensive Agents (administration & dosage, therapeutic use, urine)
  • Blood Pressure Determination
  • Blood Pressure Monitoring, Ambulatory
  • Coronary Vasospasm (drug therapy, psychology, urine)
  • Diuretics (administration & dosage, therapeutic use, urine)
  • Feasibility Studies
  • Female
  • Fluorometry
  • Humans
  • Hypertension (drug therapy, psychology, urine)
  • Male
  • Medication Adherence
  • Middle Aged
  • Pilot Projects
  • Sensitivity and Specificity
  • Triamterene (administration & dosage, therapeutic use, urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: